Tin- and Chromium-Coated Steel Sheet From Japan; Determination, 29568-29569 [2018-13504]

Download as PDF 29568 Federal Register / Vol. 83, No. 122 / Monday, June 25, 2018 / Notices establish guidelines and procedures for the processing of these applications. Title of Collection: Conveyance of Federally-Owned Mineral Interests. OMB Control Number: 1004–0153. Form Numbers: None. Type of Review: Extension of a currently approved collection. Respondents/Affected Public: Owners of surface estates (i.e., individuals, businesses, or state, local, or tribal governments) that want to obtain underlying Federally-owned mineral estates. Total Estimated Number of Annual Respondents: 5. Total Estimated Number of Annual Responses: 5. Estimated Completion Time per Response: 1 hour. Total Estimated Number of Annual Burden Hours: 5. Respondent’s Obligation: Required to Obtain or Retain a Benefit. Frequency of Collection: On occasion. Total Estimated Annual Nonhour Burden Cost: $250. An agency may not conduct or sponsor and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. The authority for this action is the Paperwork Reduction Act of 1995 (44 U.S.C. 3501 et seq.). Jean Sonneman, Information Collection Clearance Officer, Bureau of Land Management. [FR Doc. 2018–13579 Filed 6–22–18; 8:45 am] BILLING CODE 4310–84–P INTERNATIONAL TRADE COMMISSION [Investigation No. 731–TA–1383 (Final)] Stainless Steel Flanges From China; Supplemental Schedule for the Subject Investigation United States International Trade Commission. ACTION: Notice. AGENCY: amozie on DSK3GDR082PROD with NOTICES1 FOR FURTHER INFORMATION CONTACT: Celia Feldpausch (202–205–2387), Office of Investigations, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436. Hearing-impaired persons can obtain information on this matter by contacting the Commission’s TDD terminal on 202– 205–1810. Persons with mobility impairments who will need special assistance in gaining access to the Commission should contact the Office of the Secretary at 202–205–2000. General information concerning the VerDate Sep<11>2014 17:58 Jun 22, 2018 Jkt 244001 Commission may also be obtained by accessing its internet server (https:// www.usitc.gov). The public record for these investigations may be viewed on the Commission’s electronic docket (EDIS) at https://edis.usitc.gov. SUPPLEMENTARY INFORMATION: Effective January 23, 2018, the Commission established a general schedule for the conduct of the final phase of its investigations on stainless steel flanges from China and India,1 following a preliminary determination by the U.S. Department of Commerce (‘‘Commerce’’) that imports of the subject stainless steel flanges were subsidized by the government of China. Notice of the scheduling of the final phase of the Commission’s investigations and of a public hearing to be held in connection therewith was given by posting copies of the notice in the Office of the Secretary, U.S. International Trade Commission, Washington, DC, and by publishing the notice in the Federal Register of February 7, 2018 (83 FR 5459). The hearing was held in Washington, DC, on April 10, 2018, and all persons who requested the opportunity were permitted to appear in person or by counsel. To date, Commerce has issued final affirmative determinations with respect to the subject stainless steel flanges from China.2 3 The Commission subsequently issued its final affirmative determination regarding subsidized imports from China on May 29, 2018 (83 FR 25714, June 4, 2018). The Commission currently is issuing a supplemental schedule for its antidumping duty investigation on imports of stainless steel flanges from China. This supplemental schedule is as follows: The deadline for filing supplemental party comments on Commerce’s final antidumping duty determination regarding China is June 25, 2018. Supplemental party comments may address only Commerce’s final antidumping duty determination regarding imports of certain stainless steel flanges from China. These supplemental final comments may not contain new factual information and may not exceed five (5) pages in length. The supplemental staff report in this 1 Stainless Steel Flanges from China and India: Scheduling of the Final Phase of Countervailing Duty and Antidumping Duty Investigations, 83 FR 5459, February 7, 2018. 2 Countervailing Duty Investigation of Stainless Steel Flanges From the People’s Republic of China: Final Affirmative Determination, 83 FR 15790, April 12, 2018. 3 Stainless Steel Flanges From the People’s Republic of China: Final Affirmative Determination of Sales at Less than Fair Value, 83 FR 26959, June 11, 2018. PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 antidumping duty investigation will be placed in the nonpublic record and a public version will be issued thereafter. For further information concerning these investigations, see the Commission’s notice cited above and the Commission’s Rules of Practice and Procedure, part 201, subparts A and B (19 CFR part 201), and part 207, subparts A and C (19 CFR part 207). Authority: These investigations are being conducted under authority of title VII of the Tariff Act of 1930; this notice is published pursuant to section 207.21 of the Commission’s rules. By order of the Commission. Issued: June 20, 2018. Lisa Barton, Secretary to the Commission. [FR Doc. 2018–13557 Filed 6–22–18; 8:45 am] BILLING CODE 7020–02–P INTERNATIONAL TRADE COMMISSION [Investigation No. 731–TA–860 (Third Review)] Tin- and Chromium-Coated Steel Sheet From Japan; Determination On the basis of the record 1 developed in the subject five-year review, the United States International Trade Commission (‘‘Commission’’) determines, pursuant to the Tariff Act of 1930 (‘‘the Act’’), that revocation of the antidumping duty order on tin- and chromium-coated steel sheet from Japan would be likely to lead to continuation or recurrence of material injury to an industry in the United States within a reasonably foreseeable time. Background The Commission, pursuant to section 751(c) of the Act (19 U.S.C. 1675(c)), instituted this review on May 1, 2017 (82 FR 20378) and determined on August 4, 2017 that it would conduct a full review (82 FR 40168, August 24, 2017). Notice of the scheduling of the Commission’s review and of a public hearing to be held in connection therewith was given by posting copies of the notice in the Office of the Secretary, U.S. International Trade Commission, Washington, DC, and by publishing the notice in the Federal Register on October 20, 2017 (82 FR 49661). The hearing was held in Washington, DC, on February 27, 2018, and all persons who requested the opportunity were permitted to appear in person or by counsel. 1 The record is defined in sec. 207.2(f) of the Commission’s Rules of Practice and Procedure (19 CFR 207.2(f)). E:\FR\FM\25JNN1.SGM 25JNN1 Federal Register / Vol. 83, No. 122 / Monday, June 25, 2018 / Notices The Commission made this determination pursuant to section 751(c) of the Act (19 U.S.C. 1675(c)). It completed and filed its determination in this review on June 19, 2018. The views of the Commission are contained in USITC Publication 4795 (June 2018), entitled Tin- and Chromium-Coated Steel Sheet from Japan: Investigation No. 731–TA–860 (Third Review). By order of the Commission. Issued: June 19, 2018. Lisa Barton, Secretary to the Commission. [FR Doc. 2018–13504 Filed 6–22–18; 8:45 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Drug Enforcement Administration amozie on DSK3GDR082PROD with NOTICES1 Decision and Order: Mohammed Asgar, M.D. On March 29, 2017, the Assistant Administrator, Diversion Control Division, Drug Enforcement Administration (hereinafter, DEA), issued an Order to Show Cause to Mohammed Asgar, M.D. (hereinafter, Respondent), of Gary, Indiana.1 GX 6 (Order to Show Cause), at 1. The Show Cause Order proposed the revocation of Respondent’s DEA Certificate of Registration as a practitioner, on the ground that the U.S. Department of Health and Human Services, Office of Inspector General (hereinafter, HHS OIG) notified Respondent of his ‘‘mandatory exclusion from participation in all Federal health care programs for a minimum period of five years pursuant to 42 U.S.C. 1320a–7(a).’’ Id. at 2 (citing 21 U.S.C. 824(a)(5)). The Show Cause Order also proposed the denial of any pending application by Respondent to modify or renew his registration. Id. at 1. As for the Agency’s jurisdiction, the Show Cause Order alleged that Respondent holds DEA Certificate of Registration No. FA3926055, which authorizes him to dispense controlled substances in schedules II through V as a practitioner, at the registered address of 600 Grant Street, Gary, Indiana 46402. Id. The Show Cause Order alleged that this registration expires on June 30, 2019. GX 6, at 2. As to the substantive ground for the proceeding, the Show Cause Order specifically alleged that Respondent was ‘‘notified by . . . [the HHS OIG] of . . . [his] mandatory exclusion from participation in all Federal health care 1 The Show Cause Order caption also listed an address in Posen, Illinois for Respondent. VerDate Sep<11>2014 17:58 Jun 22, 2018 Jkt 244001 programs for a minimum period of five years pursuant to 42 U.S.C. 1320a–7(a).’’ GX 6, at 2. It asserted that, ‘‘[m]andatory exclusion from Medicare is an independent ground for revoking a DEA registration pursuant to 21 U.S.C. 824(a)(5).’’ Id. The Show Cause Order further asserted that ‘‘although your conviction was unrelated to your handling of controlled substances, DEA has nevertheless found that the underlying conviction forming the basis for a registrant’s exclusion from participating in federal health care programs need not involve controlled substances for revocation under 21 U.S.C. 824(a)(5)’’ to be warranted. Id. The Show Cause Order notified Respondent of his right to request a hearing on the allegations, or to submit a written statement in lieu of a hearing, the procedures for electing each option, and the consequences for failing to elect either option. Id. at 2–3 (citing 21 CFR 1301.43). The Show Cause Order also notified Respondent of his right to submit a corrective action plan under 21 U.S.C. 824(c)(2)(C). Id. at 3. By letter dated April 27, 2017, Respondent’s counsel acknowledged service of the Show Cause Order on April 4, 2017, waived Respondent’s right to a hearing, and stated that he was filing Respondent’s written response to the Show Cause Order. GX 7 (Written Statement), at 1. Attached to the Written Statement are the Show Cause Order, 22 letters ‘‘submitted voluntarily by patients and colleagues’’ of Respondent, the transcript of Respondent’s Sentencing Hearing, and the Government’s Sentencing Memorandum concerning Respondent. Id. at 2. On October 13, 2017, DEA submitted a Request for Final Agency Action (RFAA) including an evidentiary record to support the Show Cause Order’s allegations and Respondent’s Written Statement and attachments. I issue this Decision and Order based on the entire record before me. 21 CFR 1301.43(e). I make the following findings of fact. Findings of Fact Respondent’s DEA Registration Respondent is the holder of DEA Certificate of Registration No. FA3926055, pursuant to which he is authorized to dispense controlled substances in schedules II through V as a practitioner, at the registered address of 600 Grant Street, Gary, Indiana 46402. GX 1 (copy of registration); GX 2 (Certification of Registration Status), at 1. This registration expires on June 30, 2019. GX 1; GX 2, at 1. PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 29569 The Nature and Scope of Respondent’s Criminality Respondent’s criminal conduct began in Chicago in or about 2005. GX 3 (Plea Agreement, United States v. Asgar, No. 12 CR 491–10 (N.D. Ill. Dec. 18, 2014) (hereinafter, Plea Agreement)), at 2. At this time, Respondent and another medical doctor, Dr. Farzana Begum, ‘‘conspired with each other to knowingly and willfully refer Medicare beneficiaries to Grand Home Health for the provision of home health care services in exchange for illegal cash kickback payments.’’ Id. at 2–3. Each Medicare patient that the doctors referred resulted in a cash payment of $400 to Dr. Begum. Id. at 3. According to the Plea Agreement, Respondent ‘‘knew that it was illegal to solicit and receive kickbacks . . . in exchange for . . . referrals of Medicare patients.’’ Id. ‘‘From in or about January 2006 through May 2008,’’ Dr. Begum received about ‘‘$141,100 in kickbacks in exchange for [Respondent’s] referral of Medicare beneficiaries to Grand Home Health.’’ Id. The relationship between Respondent and Dr. Begum ended in approximately May 2008. Id. As a result, Respondent ended the arrangement under which Dr. Begum received cash kickbacks in exchange for Respondent’s Medicare patient referrals. Id. About six months later, however, the cash kickback payments resumed. This time, Respondent received cash kickbacks in exchange for his referral of Medicare patients to Grand Home Health. Id. On or about February 9, 2011, for example, Respondent received $1,500 in cash for his referral of three patients to Grand Home Health ‘‘for the furnishing of home health care services for which payment may be made in whole and in part under Medicare.’’ Id. at 3–4. For the two-year period between about February 2009 and February 2011, Respondent received about $15,900 in exchange for his referral of Medicare beneficiaries to Grand Home Health. Id. at 4. By May 2011, the Government was investigating the conspiracy. Id. On or about May 3, 2011, Respondent met with an individual who was cooperating with the investigation and recording the meeting. Id. During the meeting, Respondent received about $1,500 in exchange for the referral of three Medicare patients to Grand Home Health. Id. At another meeting that was recorded by a different individual, Respondent urged the individual to ‘‘deny right away’’ if anyone raised the kickback conspiracy. Id. Respondent said, ‘‘So E:\FR\FM\25JNN1.SGM 25JNN1

Agencies

INTERNATIONAL TRADE COMMISSION

[Federal Register Volume 83, Number 122 (Monday, June 25, 2018)]
[Notices]
[Pages 29568-29569]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-13504]


-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 731-TA-860 (Third Review)]


Tin- and Chromium-Coated Steel Sheet From Japan; Determination

    On the basis of the record \1\ developed in the subject five-year 
review, the United States International Trade Commission 
(``Commission'') determines, pursuant to the Tariff Act of 1930 (``the 
Act''), that revocation of the antidumping duty order on tin- and 
chromium-coated steel sheet from Japan would be likely to lead to 
continuation or recurrence of material injury to an industry in the 
United States within a reasonably foreseeable time.
---------------------------------------------------------------------------

    \1\ The record is defined in sec. 207.2(f) of the Commission's 
Rules of Practice and Procedure (19 CFR 207.2(f)).
---------------------------------------------------------------------------

Background

    The Commission, pursuant to section 751(c) of the Act (19 U.S.C. 
1675(c)), instituted this review on May 1, 2017 (82 FR 20378) and 
determined on August 4, 2017 that it would conduct a full review (82 FR 
40168, August 24, 2017). Notice of the scheduling of the Commission's 
review and of a public hearing to be held in connection therewith was 
given by posting copies of the notice in the Office of the Secretary, 
U.S. International Trade Commission, Washington, DC, and by publishing 
the notice in the Federal Register on October 20, 2017 (82 FR 49661). 
The hearing was held in Washington, DC, on February 27, 2018, and all 
persons who requested the opportunity were permitted to appear in 
person or by counsel.

[[Page 29569]]

    The Commission made this determination pursuant to section 751(c) 
of the Act (19 U.S.C. 1675(c)). It completed and filed its 
determination in this review on June 19, 2018. The views of the 
Commission are contained in USITC Publication 4795 (June 2018), 
entitled Tin- and Chromium-Coated Steel Sheet from Japan: Investigation 
No. 731-TA-860 (Third Review).

    By order of the Commission.

    Issued: June 19, 2018.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2018-13504 Filed 6-22-18; 8:45 am]
 BILLING CODE 7020-02-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.